IDSA resorts to name-calling to discredit opposing viewpoints
By Lyme Times Staff
Lyme Studies show benefit of extended treatment
By Lyme Times Staff
Key issues in The Lyme Debate help clarify confusing differences
By Lyme Times Staff
Physicians beware low quality evidence
By Lyme Times Staff
Conflicting guidelines reflect deeply divided medical community
By Lyme Times Staff
How Monopoly power triggered an antitrust investigation into the IDSA.
By Lyme Times Staff
Treatment Guidelines must recognize competing evidence and viewpoints
By Lyme Times Staff
IDSA Lyme Guidelines review panel rubberstamps status quo
By Lyme Times Staff
Dueling guidelines permitted in other specialities
By Lyme Times Staff
Informed choice goes beyond informed consent
By Lyme Times Staff
LymeDisease.org advocates for patient perspective in the guideline process
By Lorraine Johnson, JD, MBA
LLMD clinical experience informs patient options
By Daniel Cameron, MD, MPH
JOIN & RECEIVE ACCESS TOLYMETIMES
You don’t have access to the LymeTimes Winter 2011 Issue. Become a member and get immediate access to all LymeTimes issues.
Subscribe to our mailing list and get Lyme disease news updates to your email inbox.
We respect your privacy and take protecting it seriously.